Overview Financials News + Filings Key Docs Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
Apellis Pharmaceuticals, Inc. (APLS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in Apellis Pharmaceuticals Inc |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.3% stake in Apellis Pharmaceuticals Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Morningside Venture Investments Ltd reports a 13.2% stake in APELLIS PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 0% stake in Apellis Pharmaceuticals, Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Morningside Venture Investments Ltd reports a 15.8% stake in APELLIS PHARMACEUTICALS, INC. |
| 02/16/2021 |
SC 13G/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 6.6% stake in Apellis Pharmaceuticals, Inc. |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.4% stake in Apellis Pharmaceuticals Inc |
| 05/24/2019 |
SC 13G/A
| Morningside Venture Investments Ltd reports a 19.3% stake in APELLIS PHARMACEUTICALS, INC. |
| 03/22/2019 |
SC 13G/A
| Morningside Venture Investments Ltd reports a 19.3% stake in APELLIS PHARMACEUTICALS, INC. |
| 03/13/2019 |
SC 13G/A
| Morningside Venture Investments Ltd reports a 19.3% stake in APELLIS PHARMACEUTICALS, INC. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Hillhouse Capital Advisors, Ltd. reports a 4% stake in Apellis Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 7.5% stake in Apellis Pharmaceuticals, Inc. |
|
|